Patient Safety Commissioner redress project (July 2023)

Summary

In 2020, the Independent Medicines and Medical Devices Safety Review (IMMDS), chaired by Baroness Cumberlege, highlighted the avoidable harm caused by both pelvic and sodium valproate. It also set out the devastating impact on people’s lives when patients’ voices go unheard.

The Minister for Mental Health and Women’s Health Strategy, Maria Caulfield MP, asked the Patient Safety Commissioner (PSC) to explore redress options for those who have been harmed by pelvic mesh and sodium valproate. The work will focus on what a suitable redress scheme for those affected should look like, to meet the needs of those affected. The PSC will publish a public report of this work. Once the project is complete, the Government will consider the report and set out next steps.

The project will engage with patients through:

• meeting patients and their representative organisations.
• an online survey to gather views, which will be launched in due course.

Content

Further reading

Financial redress: A report about a report, following a report (Sling the Mesh, 15 July 2023)